💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

S&P 500 tops 3,000 on hopes of economic recovery, COVID-19 vaccine

Published 05/26/2020, 09:32 AM
Updated 05/26/2020, 12:19 PM
© Reuters. New York Stock Exchange opens during COVID-19
US500
-
DJI
-
MRK
-
IXIC
-
NVAX
-
CCL
-
SPSY
-
SPLRCI
-

By Medha Singh and Uday Sampath Kumar

(Reuters) - U.S. stocks jumped and the S&P 500 breached 3,000 points on Tuesday as optimism about a potential coronavirus vaccine and a revival in business activity helped investors overlook simmering Sino-U.S. tensions.

The benchmark index traded above the key psychological level for the first time since March 5, but came off session highs as White House adviser Larry Kudlow said President Donald Trump was "so miffed with China on virus and other matters that the trade deal is not as important to him as it once was".

Still, all 11 S&P sector indexes were trading higher, with cyclical financials (SPSY), industrials (SPLRCI) and energy <.SPNU> stocks jumping between 3.5% and 5%.

The S&P 500 has risen about 37% from its March lows on a raft of central bank and government stimulus and is now just about 11% below its February record high.

On Monday, California decided to reopen in-store retail businesses and places of worship from one of the most restrictive shutdowns in the United States.

"People have been locked up and when they see sparkles of hope like vaccines, that drives optimism probably ahead of where it should be and clearly ahead of the economy," said Richard Steinberg, chief market strategist at Colony Group in Florida.

Data showed U.S. consumer confidence nudged up in May, adding to hopes the worst of the impact of the shutdown in economic activity was probably in the past.

At 11:41 a.m. ET, the Dow Jones Industrial Average (DJI) was up 605.49 points, or 2.47%, at 25,070.65, the S&P 500 (SPX) was up 50.32 points, or 1.70%, at 3,005.77, and the Nasdaq Composite (IXIC) was up 66.52 points, or 0.71%, at 9,391.11.

U.S. biotech group Novavax Inc (O:NVAX) jumped 14.7% as it joined the race to test coronavirus vaccine candidates on humans and enrolled its first participants. Merck & Co Inc (N:MRK) added 2.3% as it announced plans to develop two separate vaccines.

But with U.S. unemployment soaring beyond 14% and macroeconomic data pointing at a deep recession, analysts warned financial markets could be betting on too fast a recovery.

"The impact on the economy and corporate earnings will be seen for several quarters (and) I'm not sure if it has been completely baked into the equity prices," Robert Wyrick, chief investment officer at Post Oak Private Wealth Advisors in Houston, Texas told the Reuters Global Markets Forum.

Beaten down travel-related stocks soared, with S&P 1500 airlines index <.SPCOMAIR> up 10.8% and cruise operators including Carnival Corp (N:CCL) more than 12.3%.

Advancing issues outnumbered decliners more than 6-to-1 on the NYSE and 3-to-1 on the Nasdaq.

The S&P index recorded 13 new 52-week highs and no new low, while the Nasdaq recorded 96 new highs and seven new lows.

© Reuters. Traders wearing masks work, on the first day of in-person trading since the closure during the outbreak of the coronavirus disease (COVID-19) on the floor at the NYSE in New York

S&P futures scale 3000: https://fingfx.thomsonreuters.com/gfx/mkt/jbyvrljamve/Pasted%20image%201590479196024.png

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.